DE3780480D1 - Test fuer menschlichen brustkrebs. - Google Patents

Test fuer menschlichen brustkrebs.

Info

Publication number
DE3780480D1
DE3780480D1 DE8787301040T DE3780480T DE3780480D1 DE 3780480 D1 DE3780480 D1 DE 3780480D1 DE 8787301040 T DE8787301040 T DE 8787301040T DE 3780480 T DE3780480 T DE 3780480T DE 3780480 D1 DE3780480 D1 DE 3780480D1
Authority
DE
Germany
Prior art keywords
breast cancer
test
human breast
serum
sera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787301040T
Other languages
English (en)
Other versions
DE3780480T2 (de
Inventor
Peter S Linsley
Vincent W Ochs
Diane Horn
Joseph P Brown
David B Ring
Arthur E Frankel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Oncogen LP
Original Assignee
Oncogen LP
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25246638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3780480(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oncogen LP, Cetus Corp filed Critical Oncogen LP
Application granted granted Critical
Publication of DE3780480D1 publication Critical patent/DE3780480D1/de
Publication of DE3780480T2 publication Critical patent/DE3780480T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8787301040T 1986-02-05 1987-02-05 Test fuer menschlichen brustkrebs. Expired - Lifetime DE3780480T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/826,477 US4803169A (en) 1986-02-05 1986-02-05 Assay for human breast cancer

Publications (2)

Publication Number Publication Date
DE3780480D1 true DE3780480D1 (de) 1992-08-27
DE3780480T2 DE3780480T2 (de) 1993-02-18

Family

ID=25246638

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787301040T Expired - Lifetime DE3780480T2 (de) 1986-02-05 1987-02-05 Test fuer menschlichen brustkrebs.

Country Status (9)

Country Link
US (1) US4803169A (de)
EP (1) EP0232179B1 (de)
JP (1) JP2739110B2 (de)
AT (1) ATE78601T1 (de)
AU (1) AU593476B2 (de)
CA (1) CA1279006C (de)
DE (1) DE3780480T2 (de)
ES (1) ES2033823T3 (de)
GR (1) GR3005971T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401638A (en) * 1986-06-04 1995-03-28 Oncogene Science, Inc. Detection and quantification of neu related proteins in the biological fluids of humans
US6861511B1 (en) 1986-06-04 2005-03-01 Bayer Corporation Detection and quantification of neu related proteins in the biological fluids of humans
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
EP0394510A1 (de) * 1989-04-24 1990-10-31 Mochida Pharmaceutical Co., Ltd. Verfahren zur Bestimmung eines tumorassozierten Antigens in winzigen Mengen von Brustwarzen-Ausfluss und Vorrichtung für eine solche Bestimmung
EP0491867B1 (de) * 1989-09-15 1996-11-27 Genetic Systems Corporation HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
US5411868A (en) * 1989-10-24 1995-05-02 Board Of Regents, The University Of Texas System Diagnostic and premonitoring uses of a 65 kDa tumor-associated protein in companion and domestic animal malignancy
WO1991011715A1 (en) * 1990-01-25 1991-08-08 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Detection of a characteristic antigen from carcinoma in body fluids
US5256540A (en) * 1990-12-28 1993-10-26 Mayo Foundation For Medical Education And Research Immunoassay for small cell lung carcinoma
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
JPH08502889A (ja) * 1992-10-29 1996-04-02 トーマス・ジェファーソン・ユニバーシティ 前立腺癌の微小転移を検出する方法
US5763164A (en) * 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
US20050112622A1 (en) 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522918A (en) * 1981-12-15 1985-06-11 Jeffery Schlom Process for producing monoclonal antibodies reactive with human breast cancer
NO830570L (no) * 1982-02-22 1983-08-23 Carlton Med Prod Antistoffer og antigener for diagnose og behandling av cancer
US4657851A (en) * 1984-01-03 1987-04-14 Georgetown University Breast cancer diagnostic blood test
US4753894A (en) * 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
EP0160446B1 (de) * 1984-05-01 1992-06-17 Ciba Corning Diagnostics Corp. Brusttumorassoziiertes Antigen und monoklonale Antikörper dazu
WO1986004092A1 (en) * 1984-12-28 1986-07-17 Taisho Pharmaceutical Co., Ltd. Process for preparing human cancer-specific monoclonal antibody
AU601379B2 (en) * 1985-11-07 1990-09-13 Trustees Of Columbia University In The City Of New York, The Antigen indicative of human breast cancer and assays based thereon

Also Published As

Publication number Publication date
AU6828387A (en) 1987-08-06
JPS62259064A (ja) 1987-11-11
AU593476B2 (en) 1990-02-08
EP0232179B1 (de) 1992-07-22
ATE78601T1 (de) 1992-08-15
CA1279006C (en) 1991-01-15
US4803169A (en) 1989-02-07
DE3780480T2 (de) 1993-02-18
EP0232179A2 (de) 1987-08-12
EP0232179A3 (en) 1989-09-06
GR3005971T3 (de) 1993-06-07
JP2739110B2 (ja) 1998-04-08
ES2033823T3 (es) 1993-04-01

Similar Documents

Publication Publication Date Title
Saxinger et al. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human T cell leukemia-lymphoma virus.
Yorde et al. Competitive enzyme-liked immunoassay with use of soluble enzyme/antibody immune complexes for labeling. I. Measurement of human choriogonadotropin.
DE3780480D1 (de) Test fuer menschlichen brustkrebs.
ES2009939A6 (es) Un inmunoensayo para la deteccion simultanea de antigenos yno anticuerpos en una muestra a ensayar de un fluido fisiologico.
PT838680E (pt) Determinacao de antigenios complexados especificos da prostata
DE69025940T2 (de) Durch Silber intensiviertes, auf Goldmarkierung beruhendes Immuntestverfahren
FI862242A0 (fi) Monoklonala antikroppar foer ej-smaocelliga lungkraeftsvulster hos maenniska.
Migliorini et al. Cold-precipitable immune complexes in collagen diseases: evidence for the coexistence of multiple types of circulating complexes in the same serum
Smith et al. A rapid and reproducible method for the analysis of immune complexes using affinity chromatography and Western blotting
Leblanc et al. Staphylococcal protein A assay for detection of antibody directed at renal cancer cells
Negoro et al. A solid-phase radioimmunoassay for the detection of nRNP immune complexes
ATE209359T1 (de) Bestimmung von freiem und komplexiertem trypsinogen-2
DK0519536T3 (da) Diagnostisk fremgangsmåde
Ørstavik et al. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to factor IX in hemophilia B
Kithier et al. Pancreatic oncofetal antigen and carcinoembryonic antigen in breast and colon carcinoma
IE901719L (en) Methods and systems for determining the presence of a¹pneumocystis carinii antigen in blood
KR890702040A (ko) 요중의 염기성 태아단백의 측정방법 및 그것에 사용되는 측정키트

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER 1. PATENTINHABER LAUTET RICHTIG: CETUS ONCOLOGY CORP., EMERYVILLE, CALIF., US

8363 Opposition against the patent
8365 Fully valid after opposition proceedings